# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA652792 | F | Antagonist activity against C-C chemokine receptor type 3 | 2 | assay format | Scientific Literature | |||
2. | ALA653052 | F | In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay | 4 | assay format | Scientific Literature | |||
3. | ALA650419 | B | In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin | 87 | single protein format | Scientific Literature | |||
4. | ALA650420 | B | Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand | 27 | single protein format | Scientific Literature | |||
5. | ALA650590 | B | Inhibitory effect on the binding of [125I]- eotaxin to C-C chemokine receptor type 3- expressing CHO cells | 1 | cell-based format | Scientific Literature | |||
6. | ALA650591 | F | In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay | 1 | assay format | Scientific Literature | |||
7. | ALA650592 | B | In vitro inhibitory activity of compound against C-C chemokine receptor type 3 at 0.5 uM using 150p M [125I]-labeled human eotaxin as radioligand | 1 | single protein format | Scientific Literature | |||
8. | ALA874666 | B | In vitro inhibitory activity against C-C chemokine receptor type 3 at 10 uM using 150p M [125I]-labeled human eotaxin | Homo sapiens | 9 | single protein format | Scientific Literature | ||
9. | ALA650593 | B | In vitro inhibitory activity of compound against C-C chemokine receptor type 3 at 5 uM using 150p M [125I]-labeled human eotaxin as radioligand | 1 | single protein format | Scientific Literature | |||
10. | ALA650594 | B | Binding affinity towards CCR3 receptor | 1 | single protein format | Scientific Literature | |||
11. | ALA650595 | B | Inhibitory activity against C-C chemokine receptor type 3 | 7 | single protein format | Scientific Literature | |||
12. | ALA650596 | B | Compound was evaluated for its inhibitory activity against C-C chemokine receptor type 3 | 6 | single protein format | Scientific Literature | |||
13. | ALA652232 | B | The compound was tested for inhibition of Chemokine (eotaxin) binding against C-C chemokine receptor type 3 transfected in HEK 293 cells | 1 | cell-based format | Scientific Literature | |||
14. | ALA652233 | B | Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin. | 36 | single protein format | Scientific Literature | |||
15. | ALA656315 | B | Inhibitory concentration of compound against C-C chemokine receptor type 3 was determined using human [125I]eotaxin | 8 | single protein format | Scientific Literature | |||
16. | ALA881831 | B | Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
17. | ALA649974 | B | Percent inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells at 1 uM | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
18. | ALA856080 | F | Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assay | 1 | assay format | Scientific Literature | |||
19. | ALA856084 | F | Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay | 1 | assay format | Scientific Literature | |||
20. | ALA884136 | F | Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay | 1 | assay format | Scientific Literature |